Home » Newsletters » BioWorld Asia

BioWorld Asia

April 12, 2000

View Archived Issues

Artemis Raises DM36M Privately To Fund Staff, Pipeline Growth

Gemini Forms Alliances Around SNPs With CuraGen, Sequenom

Kidney Protein Discovered With Implications In Disorder

Industry Braces For Battle On Tighter Biotech Controls

Antisoma Moving Ahead After Preclinical Apoptosis Results

Bioethics Council Says Cloning Should Be Allowed For Research

Epidauros, MWG Collaborate On Pharmacogenomic DNA Chip

Queensland Researchers Patent Gene Related To Blood Vessels

Transghne Cancels Offering, Releases Gene Therapy Data

Other News To Note

Oxford Gene Gets Favorable Ruling Against Affymetrix

PPL Phase II Study Positive In Pancreatic Insufficiency

Neurotech Starts Phase I/II Study Of Endothelial Cells For Gliomas

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....